A Trial Investigating the Hypoglycaemic Response to NN1250 [Insulin degludec] in Subjects With Type 1 Diabetes.
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 12 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2010 Planned end date changed from 1 Feb 2010 to 1 Mar 2010 as reported by ClinicalTrials.gov.
- 02 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.